Bionanotechnology News

RSS

Researchers Develop Nanosized DNA Robot for Targeted Therapies

Harvard’s Wyss Institute researchers have developed a novel robotic device from DNA. The device has the capability to target specific cells and instructs them for self destruction, especially the cancerous cells.

18 Feb 2012

Market Research Report on Nanocarriers

Reportlinker has released the latest research report titled “Nanotechnology for Drug Delivery: Global Market for Nanocarriers”. According to the report, by 2021, 40% of the drug delivery market will be captured by nanocarriers. The overall market size is expected to reach $136 billion in 2021 with nanocarriers and nanocrystals being the major players.

15 Feb 2012

Nano-Bio-Electronic Alliance Formed to Develop Treatments for Neurological Diseases

The Society for Brain Mapping and Therapeutics (SBMT) has declared that it will conduct its 9th Annual World Congress on Brain, Spinal Cord Mapping, and Image Guided Therapy at the Toronto Metro Convention Center in Toronto, Canada from June 2 to 4, 2012.

15 Feb 2012

NIST-CU Collaboration Develops FRET Sensors with Timing Capability

A microfluidic system has been developed by researchers from JILA, a collaboration of the National Institute of Standards and Technology (NIST) and the University of Colorado Boulder (CU). The system tracks time in biochemical reactions in the range of milliseconds to seconds. Lasers were used for the measurement of sensor signals in the microfluidic system.

From National Institute of Standards and Tech (NIST) 10 Feb 2012

Bruker Announce Call for Papers for Seeing at the Nanoscale Conference

Bruker announced today the call for papers for the ‘Seeing at the Nanoscale 2012’ conference, which will take place at the Wills Memorial Building, University of Bristol, UK, from July 09–11, 2012.

From Bruker Nano Surfaces and Metrology 8 Feb 2012

Researchers Develop Novel Protein Nanoclusters to Help Advance Drug Delivery

A research team comprising Keith P. Johnston, Thomas M. Truskett and Jennifer Maynard from the Cockrell School of Engineering at The University of Texas at Austin has developed a novel protein formulation strategy to develop advanced drug delivery systems for treating arthritis, cancer and infectious diseases easily, efficiently and safely.

31 Jan 2012